XERISOL Trademark

Trademark Overview


On Friday, December 4, 2020, a trademark application was filed for XERISOL with the United States Patent and Trademark Office. The USPTO has given the XERISOL trademark a serial number of 90359499. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, February 13, 2024. This trademark is owned by Xeris Pharmaceuticals, Inc.. The XERISOL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders

Pharmaceutical research and development; pharmaceutical drug formulation and development services; providing information on drug technology platforms for the formulation and development of drugs and biologics
xerisol

General Information


Serial Number90359499
Word MarkXERISOL
Filing DateFriday, December 4, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, February 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders
Goods and ServicesPharmaceutical research and development; pharmaceutical drug formulation and development services; providing information on drug technology platforms for the formulation and development of drugs and biologics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXeris Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60601

Party NameXeris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601

Trademark Events


Event DateEvent Description
Wednesday, May 12, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 8, 2020NEW APPLICATION ENTERED
Wednesday, February 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 24, 2021ASSIGNED TO EXAMINER
Wednesday, May 26, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 26, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, May 26, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 26, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 16, 2021SOU TEAS EXTENSION RECEIVED
Thursday, December 16, 2021SOU EXTENSION 1 FILED
Thursday, December 16, 2021SOU EXTENSION 1 GRANTED
Thursday, May 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, May 27, 2022SOU TEAS EXTENSION RECEIVED
Saturday, December 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 27, 2022SOU EXTENSION 2 FILED
Friday, May 27, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 31, 2023SOU EXTENSION 3 FILED
Tuesday, May 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 31, 2023SOU EXTENSION 3 GRANTED
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 23, 2023SOU EXTENSION 4 GRANTED
Wednesday, August 23, 2023SOU EXTENSION 4 FILED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 5 GRANTED
Tuesday, February 13, 2024SOU EXTENSION 5 FILED
Thursday, August 1, 2024TEAS STATEMENT OF USE RECEIVED